Tauopathy and cognitive impairment in experimental diabetes mellitus

Código QR

Tauopathy and cognitive impairment in experimental diabetes mellitus

Currently, diabetes mellitus (DM) is the most common metabolic disorder, which is manifested by hyperglycemia and leads to vascular and cognitive impairment. Mechanisms of cognitive dysfunction in patients with DM remain highly unclear, thus complicating the search for effective strategies for the p...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mariia V. Matveeva, Yulia G. SamoiIova, Natalia G. Zhukova, Oksana A. Oleynik, Maria A. Rotkank
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2017
Materias:	diabetes mellitus type 1 cognitive impairment tau protein alzheimer's disease Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/6921b8907daf436097a27b7b96e31b92
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

NMR Studies of Tau Protein in Tauopathies
por: Kristine Kitoka, et al.
Publicado: (2021)

Cognitive impairment in patients with type 2 diabetes mellitus: prevalence, pathogenetic mechanisms, the effect of antidiabetic drugs
por: Olga D. Ostroumova, et al.
Publicado: (2018)

Hypoglycemia and the risk of cognitive impairment and dementia in elderly and senile patients with type 2 diabetes
por: Olga D. Ostroumova, et al.
Publicado: (2020)

Mild cognitive impairment and its management in older people
por: Eshkoor SA, et al.
Publicado: (2015)

DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies
por: Geraldine Zimmer-Bensch, et al.
Publicado: (2021)

From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution
por: Cheng YW, et al.
Publicado: (2017)

Analysis of the Role of Neurospecific Proteins in the Diagnosis of Cognitive Dysfunction in Patients with Type 1 Diabetes Mellitus
por: Yulia Gennad'evna Samoylova, et al.
Publicado: (2014)

Plasma Glutathione Levels Decreased with Cognitive Decline among People with Mild Cognitive Impairment (MCI): A Two-Year Prospective Study
por: Chieh-Hsin Lin, et al.
Publicado: (2021)

Analysis of cognitive status in patients with type 2 diabetes
por: Irina V. Gatckikh, et al.
Publicado: (2017)

Benefits of Cultural Activities on People With Cognitive Impairment: A Systematic Review
por: Laia Delfa-Lobato, et al.
Publicado: (2021)

What Are the Key Points of Treatment for Cases of Mild Cognitive Impairment? Based on the Evaluation of Cognitive Function Tasks in the ADASJcog
por: Yoshihiko Yoshii, et al.
Publicado: (2021)

Deterioro cognitivo leve y enfermedad de Alzheimer inicial en adultos mayores
por: Donoso,Archibaldo, et al.
Publicado: (2001)

Metformin effects to carbohydrate and lipids metabolism in impaired glucose tolerance patients.
por: Alexander Vasil'evich Dreval', et al.
Publicado: (2010)

Reversion From Mild Cognitive Impairment To Normal Cognition: False-Positive Error Or True Restoration Thanks To Cognitive Control Ability?
por: Chung JY, et al.
Publicado: (2019)

Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer’s Disease (sAD) Mouse Model
por: Valentina Latina, et al.
Publicado: (2021)

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease
por: Edmond Teng, et al.
Publicado: (2021)

18F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies
por: Michinori Ezura, et al.
Publicado: (2021)

Prevalence of type 2 diabetes mellitus and other abnormalities of carbohydrate metabolism depending on diagnostic criteria
por: Alexander Vasil'evich Dreval', et al.
Publicado: (2010)

Detection of activities of daily living impairment in Alzheimer's disease and mild cognitive impairment using information and communication technology
por: Sacco G, et al.
Publicado: (2012)

Effects of ApoE genotype on clinical phenotypes in early‐onset and late‐onset Alzheimer's disease in China: Data from the PUMCH dementia cohort
por: Liling Dong, et al.
Publicado: (2021)

Pattern of cerebral hyperperfusion in Alzheimer's disease and amnestic mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging: initial experience
por: Ding B, et al.
Publicado: (2014)

Associations of the Glycaemic Control of Diabetes with Dementia and Physical Function in Rural-Dwelling Older Chinese Adults: A Population-Based Study
por: Jia Y, et al.
Publicado: (2021)

Gut microbiota, cognitive frailty and dementia in older individuals: a systematic review
por: Ticinesi A, et al.
Publicado: (2018)

Exercise priming with transcranial direct current stimulation: a study protocol for a randomized, parallel-design, sham-controlled trial in mild cognitive impairment and Alzheimer’s disease
por: Celina S. Liu, et al.
Publicado: (2021)

Effects of Meditation on Structural Changes of the Brain in Patients With Mild Cognitive Impairment or Alzheimer’s Disease Dementia
por: Madhukar Dwivedi, et al.
Publicado: (2021)

Effect of Memo®, a natural formula combination, on Mini-Mental State Examination scores in patients with mild cognitive impairment
por: Yakoot M, et al.
Publicado: (2013)

Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
por: Sherif Bayoumy, et al.
Publicado: (2021)

RISK FACTORS OF COGNITIVE IMPAIRMENT IN PARKINSON’S DISEASE AND DISCIRCULATORY ENCEPHALOPATHY
por: S. B. Sayutina, et al.
Publicado: (2017)

Body, Brain, Life for Cognitive Decline (BBL-CD): protocol for a multidomain dementia risk reduction randomized controlled trial for subjective cognitive decline and mild cognitive impairment
por: McMaster M, et al.
Publicado: (2018)

The Influence of MTHFR Polymorphism on Gray Matter Volume in Patients With Amnestic Mild Cognitive Impairment
por: Mengzhe You, et al.
Publicado: (2021)

Salivary Biomarkers in Alzheimer´s Disease
por: Santos,Gustavo A. A, et al.
Publicado: (2020)

Apolipoprotein ε7 allele in memory complaints: insights through protein structure prediction
por: Youn YC, et al.
Publicado: (2017)

The Potential of Naturalistic Eye Movement Tasks in the Diagnosis of Alzheimer’s Disease: A Review
por: Megan Rose Readman, et al.
Publicado: (2021)

Safety and effectiveness of ipragliflozin in Japanese patients with type 2 diabetes mellitus and impaired renal function: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM)
por: K. Tobe, et al.
Publicado: (2021)

Endocrinology research centre statement about COVID-19 vaccination of diabetes mellitus patients
por: I. I. Dedov, et al.
Publicado: (2021)

Large-Scale Functional Networks, Cognition and Brain Structures Supporting Social Cognition and Theory of Mind Performance in Prodromal to Mild Alzheimer’s Disease
por: Jose Manuel Valera-Bermejo, et al.
Publicado: (2021)

Diffusion Tensor Imaging Study of Olfactory Identification Deficit in Patients With Mild Cognitive Impairment
por: Yongjia Shao, et al.
Publicado: (2021)

Resolution on Diabetes Mellitus from United Nations organization
por: Editorial team Diabetes Mellitus
Publicado: (2007)

Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives
por: Vyronia Vassilakopoulou, et al.
Publicado: (2021)

Metformin regulates glycemic homeostasis in patients with type 2 diabetes mellitus as an NO donor
por: Ivan Sergeevich Kuznetsov, et al.
Publicado: (2013)